Vaccination with a cocktail of 12 melanoma peptides restricted by Class I MHC molecules (12MP, NSC#728925) plus a tetanus toxoid helper peptide (tet, NSC#728927) induced CD8+ T cell responses to the 12MP in 100% of patients6. This evidence concerns the gene CD8A and melanoma.